Role of Age-Related Changes in DNA Methylation in the Disproportionate Susceptibility and Worse Outcomes of Sepsis in Older Adults

Xiabing Lang, Lingling Shen, Tingting Zhu, Wenjun Zhao, Yang Chen, Chaohong Zhu, Qun Su, Cuili Wang, Yucheng Wang, Francesco Neri, Hong Jiang, Jianghua ChenFrontiers in Medicine 2022 · DOI

TL;DR

This study investigates how age-related changes in DNA methylation contribute to the increased susceptibility and poorer outcomes of sepsis in older adults. By analyzing genome-wide methylation patterns in blood samples, researchers identified specific DNA methylation sites that are altered with age and are also associated with sepsis risk and severity, suggesting a potential mechanistic link.

What Problem Does This Paper Address?

Sepsis is a life-threatening condition that disproportionately affects older adults, leading to higher hospitalization rates and mortality. Despite this known vulnerability, the underlying biological mechanisms that make the elderly more susceptible to sepsis and experience worse outcomes remain poorly understood. While aging is a known risk factor, the specific molecular pathways involved are unclear. This paper aims to bridge this knowledge gap by exploring the role of epigenetics, specifically DNA methylation, in the context of age-related sepsis susceptibility and prognosis.

Methods

The study employed a multi-stage approach:

  • Genome-Wide Methylation Profiling: Peripheral blood samples from sepsis patients and age-matched healthy controls were analyzed using the Illumina HumanMethylation450 BeadChip array. This technique allows for the assessment of methylation status at hundreds of thousands of CpG sites across the genome.
  • Bioinformatic Analysis: Raw methylation data was processed for quality control, batch correction, and normalization. Statistical methods, including linear regression and the Benjamini & Hochberg method for multiple testing correction, were used to identify differentially methylated positions (DMPs) and methylation variable positions (MVPs).
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Enrichment Analysis: These analyses were performed to understand the biological pathways and functions associated with the identified DMPs.
  • Validation Cohort: An independent cohort of sepsis patients and controls was used to validate key findings, specifically focusing on the methylation status of a selected CpG site.
  • Pyrosequencing: This technique was used in the validation phase to precisely quantify DNA methylation levels at specific CpG sites.

Datasets

  • Discovery Cohort: Peripheral blood samples from 24 sepsis patients (aged 16-88 years) and 12 healthy controls (aged 22-84 years).
  • Validation Cohort: Peripheral blood samples from 48 sepsis patients and 48 controls.

Key Insights and Ideas

  • Age is a Major Driver of Methylation Changes in Sepsis: The study found a significant overlap between age-related methylation changes in healthy individuals and methylation changes observed in sepsis patients, particularly in older individuals. This suggests that the aging process itself primes the epigenome in a way that increases vulnerability to sepsis.
  • Specific CpG Sites Link Age and Sepsis Outcomes: The researchers identified distinct sets of CpG sites that are both age-related and associated with sepsis susceptibility (241 sites) and worse outcomes (161 sites). This provides concrete molecular targets for understanding and potentially intervening in age-related sepsis pathology.
  • TGF-β and mTOR Signaling Pathways are Implicated: Enrichment analysis revealed that genes associated with age-related methylation changes in sepsis are involved in crucial pathways like TGF-β signaling (linked to susceptibility) and mTOR signaling (linked to worse outcomes). These pathways are known to be involved in immune regulation, inflammation, and aging processes.
  • DNA Methylation as a Biomarker and Mechanistic Factor: The findings suggest that age-related DNA methylation patterns could serve as biomarkers for predicting sepsis risk and prognosis in older adults. More importantly, they propose that these epigenetic changes are not just correlative but may actively contribute to the observed disparities.

Key Results

  • Sepsis-Associated Methylation Variable Positions (MVPs): 8,437 CpG sites were identified as differentially methylated between sepsis patients and controls.
  • Age-Related Susceptibility: 241 CpG sites showed age-related changes in controls and were implicated in the increased risk of sepsis in older adults.
  • Age-Related Worse Outcomes: 161 CpG sites showed methylation changes correlated with age in sepsis patients, potentially explaining worse outcomes in the elderly.
  • Validation: A specific CpG site in the VAC14 gene was validated, showing increased methylation with age and in non-survivors, supporting the study's findings.

Limitations and Future Work

  • Discovery Cohort Size: The authors acknowledge that the size of the discovery cohort was relatively small, which could limit the generalizability of some findings.
  • Inability to Test Gene Expression: A significant limitation is the inability to directly test the relationship between identified age-related DNA methylation changes and the expression of nearby genes. Future studies are needed to explore gene expression and the exact mechanisms by which these genes contribute to sepsis.
  • Functional Validation: While a specific CpG site was validated, further functional studies are required to fully elucidate the mechanistic roles of the identified age-related CpG sites in sepsis pathogenesis.
  • Intervention Studies: The findings open avenues for exploring anti-aging interventions or targeted epigenetic therapies to mitigate sepsis risk and improve outcomes in the elderly.

Summary updated

Abstract

Sepsis, a complex multisystem disorder, is among the top causes of hospitalization and mortality in older adults. However, the mechanisms underlying the disproportionate susceptibility to sepsis and worse outcomes in the elderly are not well understood. Recently, changes in DNA methylation have been shown to be linked to aging processes and age-related diseases. Thus, we postulated that age-related changes in DNA methylation may play a role in the onset and prognosis of sepsis in elderly patients. Here, we performed genome-wide methylation profiling of peripheral blood from patients with sepsis and controls. Among the CpG sites whose methylation changes may contribute to an increase in sepsis susceptibility or mortality, 241 sites that possessed age-related changes in DNA methylation in controls may partly explain the increased risk of sepsis in older adults, and 161 sites whose methylation significantly correlated with age in sepsis group may be the potential mechanisms underlying the worse outcomes of elderly septic patients. Finally, an independent cohort was used to validate our findings. Together, our study demonstrates that age-related changes in DNA methylation may explain in part the disproportionate susceptibility and worse outcomes of sepsis in older adults.
BibTeX
@inproceedings{lang2022role,
  author = {Xiabing Lang and Lingling Shen and Tingting Zhu and Wenjun Zhao and Yang Chen and Chaohong Zhu and Qun Su and Cuili Wang and Yucheng Wang and Francesco Neri and Hong Jiang and Jianghua Chen},
  title = {{Role of Age-Related Changes in DNA Methylation in the Disproportionate Susceptibility and Worse Outcomes of Sepsis in Older Adults}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.822847},
}
Figure